InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
29%
T+90 mean return
-5.8%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Pannu Geraldine, Director. Director active across 2 companies, notably Processa Pharmaceuticals, Inc.. In total, 12 disclosures have been published. History available since 18 January 2023. The latest transaction was filed on 21 May 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations12 total
2,821 shares0Common Stock, No Par ValueSEC:0001437749-25-018216:0
700 shares0Common Stock, No Par ValueSEC:0001437749-25-017366:0
800 shares0Common Stock, No Par ValueSEC:0001437749-24-017533:0
600 shares0Common Stock, No Par ValueSEC:0001437749-24-001773:0
4,500 shares@ US$0.21100.0% of flowCommon StockSEC:0000897069-23-001446:0
23,636 sharesCommon StockSEC:0000897069-23-000998:0
800 shares0Common Stock, No Par ValueSEC:0001437749-23-001512:0
18,208 sharesCommon StockSEC:0001567619-23-000314:0
1,169 sharesCommon StockSEC:0001567619-22-015309:0
4,393 sharesCommon StockSEC:0001567619-22-008010:0
1,169 sharesCommon StockSEC:0001567619-21-014759
1,169 sharesCommon StockSEC:0001567619-21-014759:0
12 of 12 declarations
About Pannu Geraldine
Geraldine Pannu is a Director at Processa Pharmaceuticals, Inc. She brings her expertise in strategy and governance to the board. As a board member, Geraldine Pannu plays a crucial role in strategic decision-making and overseeing the company's performance. Her experience in the pharmaceutical sector is a valuable asset for Processa Pharmaceuticals.
